BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21054951)

  • 1. Augmenting therapy of ovarian cancer efficacy by secreting IL-21 human umbilical cord blood stem cells in nude mice.
    Hu W; Wang J; Dou J; He X; Zhao F; Jiang C; Yu F; Hu K; Chu L; Li X; Gu N
    Cell Transplant; 2011; 20(5):669-80. PubMed ID: 21054951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor efficacy induced by human ovarian cancer cells secreting IL-21 alone or combination with GM-CSF cytokines in nude mice model.
    Dou J; Wang Y; Wang J; Zhao F; Li Y; Cao M; Hu W; Hu K; He XF; Chu L; Jiang C; Gu N
    Immunobiology; 2009; 214(6):483-92. PubMed ID: 19389515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment, characterization, and successful adaptive therapy against human tumors of NKG cell, a new human NK cell line.
    Cheng M; Ma J; Chen Y; Zhang J; Zhao W; Zhang J; Wei H; Ling B; Sun R; Tian Z
    Cell Transplant; 2011; 20(11-12):1731-46. PubMed ID: 21669033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy of ovarian cancer using IL-21-secreting human umbilical cord mesenchymal stem cells in nude mice.
    Zhang Y; Wang J; Ren M; Li M; Chen D; Chen J; Shi F; Wang X; Dou J
    J Ovarian Res; 2014 Jan; 7():8. PubMed ID: 24444073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antitumor effect of endothelial progenitor cells with TRAIL gene transfection on ovarian carcinoma xenografts in nude mice].
    Zhou L; Yan MX; Yao M; Feng YJ
    Ai Zheng; 2005 Nov; 24(11):1312-6. PubMed ID: 16552954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of IL-21 on NK cells derived from different umbilical cord blood populations.
    Perez SA; Mahaira LG; Sotiropoulou PA; Gritzapis AD; Iliopoulou EG; Niarchos DK; Cacoullos NT; Kavalakis YG; Antsaklis AI; Sotiriadou NN; Baxevanis CN; Papamichail M
    Int Immunol; 2006 Jan; 18(1):49-58. PubMed ID: 16291655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconstitution of human lymphocytes following ex vivo expansion of human umbilical cord blood CD34+ cells and transplantation in Rag2-/- gamma c-/- mice model.
    Choi BK; Joo SY; Moon C; Park KS; Kim SH; Park JB; Jung GO; Choi GS; Kwon CH; Chun JM; Joh JW; Lee SK; Kim SJ
    Transplant Proc; 2008 Oct; 40(8):2655-60. PubMed ID: 18929829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of natural killer-cell depletion on ex vivo expansion of hematopoietic progenitor cells from umbilical cord blood.
    Sun R; Wei H; Zhang J; Tian Z
    Haematologica; 2003 May; 88(5):561-9. PubMed ID: 12745276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of lymphokine activated killer from umbilical blood on human ovarian cancer in nude mouse models].
    He YD; Peng ZL; Liu SL; Wang H; Pan XL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Sep; 38(5):810-2. PubMed ID: 17953364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of NKG2A/CD94 and low expression of granzyme B are associated with reduced cord blood NK cell activity.
    Wang Y; Xu H; Zheng X; Wei H; Sun R; Tian Z
    Cell Mol Immunol; 2007 Oct; 4(5):377-82. PubMed ID: 17976318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
    Gaddy J; Broxmeyer HE
    Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human umbilical blood mononuclear cell-derived mesenchymal stem cells serve as interleukin-21 gene delivery vehicles for epithelial ovarian cancer therapy in nude mice.
    Hu W; Wang J; He X; Zhang H; Yu F; Jiang L; Chen D; Chen J; Dou J
    Biotechnol Appl Biochem; 2011; 58(6):397-404. PubMed ID: 22172102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells.
    Rabinowich H; Vitolo D; Altarac S; Herberman RB; Whiteside TL
    J Immunol; 1992 Jul; 149(1):340-9. PubMed ID: 1535088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric NKG2D receptor-bearing T cells as immunotherapy for ovarian cancer.
    Barber A; Zhang T; DeMars LR; Conejo-Garcia J; Roby KF; Sentman CL
    Cancer Res; 2007 May; 67(10):5003-8. PubMed ID: 17510432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on the mechanism of enhancing homing efficiency of human hematopoietic stem/progenitor cells into bone marrow after manipulation with tumor necrosis factor alpha in xenotransplanted BALB/c mouse model].
    Dai HS; Gao JT; Zhang TW; Yang Z; Che YZ; Zheng YZ
    Zhonghua Xue Ye Xue Za Zhi; 2009 Feb; 30(2):97-102. PubMed ID: 19563019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term human CD34+ stem cell-engrafted nonobese diabetic/SCID/IL-2R gamma(null) mice show impaired CD8+ T cell maintenance and a functional arrest of immature NK cells.
    André MC; Erbacher A; Gille C; Schmauke V; Goecke B; Hohberger A; Mang P; Wilhelm A; Mueller I; Herr W; Lang P; Handgretinger R; Hartwig UF
    J Immunol; 2010 Sep; 185(5):2710-20. PubMed ID: 20668220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective generation of different dendritic cell precursors from CD34+ cells by interleukin-6 and interleukin-3.
    Encabo A; Solves P; Mateu E; Sepúlveda P; Carbonell-Uberos F; Miñana MD
    Stem Cells; 2004; 22(5):725-40. PubMed ID: 15342937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of tumor necrosis factor-alpha and gamma-interferon in experimental human ovarian cancer.
    Balkwill FR; Ward BG; Moodie E; Fiers W
    Cancer Res; 1987 Sep; 47(18):4755-8. PubMed ID: 3113722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.
    Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL
    Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.